ASTOLFI, Monica
ASTOLFI, Monica
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA.
2010-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors.
1997-01-01 VOENA C; M. LADETTO; ASTOLFI M; PROVAN D; GRIBBEN JG; BOCCADORO M; PILERI A; CORRADINI P.
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations
2006-01-01 LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C
Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting.
2001-01-01 M. LADETTO; S. SAMETTI; M. ASTOLFI; P. CORRADINI; I. RICCA; D. DRANDI; A. PILERI; C. TARELLA
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma.
1996-01-01 Corradini P; Ladetto M; Astolfi M; Voena C; Tarella C; Bacigalupo A; Pileri A
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma.
2001-01-01 LADETTO M; ZALLIO F; VALLET S; RICCA I; CUTTICA A; CARACCIOLO D; CORRADINI P; ASTOLFI M; SAMETTI S; VOLPATO F; BONDESAN P; VITOLO U; M. BOCCADORO; PILERI A; GIANNI AM; TARELLA C.
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients
2007-01-01 Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo
Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome
2004-01-01 Marco Ladetto; Sonia Vallet; Andreas Trojan; Maria Dell’Aquila; Luigia Monitillo; Loredana Santo; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Daniela Drandi; Irene Ricca; Gloria Pagliano; Monica Astolfi; Alberto Rocci; Beata Bode; Antonio Palumbo; Corrado Tarella; Paola Omedé; Mario Boccadoro
Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2
2006-01-01 Marco Ladetto; Daniela Drandi; Loredana Santo; Barbara Mantoan; Michela Boi; Maria Dell’Aquila; Luigia Monitillo; Chiara Lobetti Bodoni; Antonio Palumbo; Monica Astolfi; Mario Boccadoro
Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients
2011-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Muccio VE; Bergui L; Coscia M; Omedè P; Boccadoro M
Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR
2006-01-01 Marco Ladetto; Monica Astolfi; Loredana Santo; Ilaria Avonto; Federica Cavallo; Gloria Pagliano; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Elisa Genuardi; Rossana Crivelli; Carmen Cristiano; Daniela Drandi; Mario Boccadoro; Antonio Palumbo
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes
2004-01-01 CORRADINI P; LADETTO M; ZALLIO F; ASTOLFI M; RIZZO E; SAMETTI S; CUTTICA A; ROSATO R; FARINA L; BOCCADORO M; BENEDETTI F; PILERI A; TARELLA C
Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL)
2004-01-01 Marco Ladetto; Barbara Mantoan; Federica De Marco; Berardino Pollio; Daniela Drandi; Irene Ricca; Sonia Vallet; Mara Compagno; Monica Astolfi; Maria Dell’Aquila; Roberto Francese; Gloria Pagliano; Luigia Monitillo; Giacomo Tamponi; Mario Boccadoro; Corrado Tarella
Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo)
2004-01-01 Marco Ladetto; Sonia Vallet; Paolo Corradini; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Paolo Coser; Alessio Perrotti; Caterina Patti; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Monica Astolfi; Alessandro Pileri; Mario Boccadoro; Corrado Tarella
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
2001-01-01 Corradini, P.; Voena, C.; Astolfi, M.; Dell'Oro, S.; Pilotti, S.; Arrigoni, G.; Bregni, M.; Pileri, A.; Gianni, A.M.
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
1999-01-01 Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A
Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma
2003-01-01 Bruno B; Ladetto M; Mordini N; Astolfi M; Rotta M; Cimolin L; Compagno M; Veneziano L; Aitoro G; Gallamini A ; Storb R; Boccadoro M
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
1997-01-01 CORRADINI P; ASTOLFI M; CHERASCO C; M. LADETTO; VOENA C; CARACCIOLO D; PILERI A; TARELLA C.
MOLECULAR REMISSION IN A MULTIPLE MYELOMA PATIENT AFTER A NON MYELOABLATIVE ALLOGENEIC TRANSPLANT: PROOF OF PRINCIPLE
2001-01-01 Bruno B; Ladetto M; Astolfi M; Sametti S; Veneziano L; Aitoro G; Giaccone L; Palumbo A; Pileri A; Boccadoro M; Storb R
PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy.
2003-01-01 Ladetto M; Drandi D; Volpato F; Astolfi M; Voena C; Compagno M; Novarino A; Pollio B; Addeo A; Ricca I; Falco P; Cavallo F; Vallet S; Corradini P; Pileri A; Tamponi G; Palumbo A; Bertetto O; Boccadoro M; Tarella C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA. | 2010 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M | |
| A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. | 1997 | VOENA C; M. LADETTO; ASTOLFI M; PROVAN D; GRIBBEN JG; BOCCADORO M; PILERI A; CORRADINI P. | |
| Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations | 2006 | LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C | |
| Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting. | 2001 | M. LADETTO; S. SAMETTI; M. ASTOLFI; P. CORRADINI; I. RICCA; D. DRANDI; A. PILERI; C. TARELLA | |
| Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma. | 1996 | Corradini P; Ladetto M; Astolfi M; Voena C; Tarella C; Bacigalupo A; Pileri A | |
| Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma. | 2001 | LADETTO M; ZALLIO F; VALLET S; RICCA I; CUTTICA A; CARACCIOLO D; CORRADINI P; ASTOLFI M; SAMETTI S; VOLPATO F; BONDESAN P; VITOLO U; M. BOCCADORO; PILERI A; GIANNI AM; TARELLA C. | |
| Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients | 2007 | Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo | |
| Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome | 2004 | Marco Ladetto; Sonia Vallet; Andreas Trojan; Maria Dell’Aquila; Luigia Monitillo; Loredana Santo; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Daniela Drandi; Irene Ricca; Gloria Pagliano; Monica Astolfi; Alberto Rocci; Beata Bode; Antonio Palumbo; Corrado Tarella; Paola Omedé; Mario Boccadoro | |
| Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2 | 2006 | Marco Ladetto; Daniela Drandi; Loredana Santo; Barbara Mantoan; Michela Boi; Maria Dell’Aquila; Luigia Monitillo; Chiara Lobetti Bodoni; Antonio Palumbo; Monica Astolfi; Mario Boccadoro | |
| Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients | 2011 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Muccio VE; Bergui L; Coscia M; Omedè P; Boccadoro M | |
| Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR | 2006 | Marco Ladetto; Monica Astolfi; Loredana Santo; Ilaria Avonto; Federica Cavallo; Gloria Pagliano; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Elisa Genuardi; Rossana Crivelli; Carmen Cristiano; Daniela Drandi; Mario Boccadoro; Antonio Palumbo | |
| Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes | 2004 | CORRADINI P; LADETTO M; ZALLIO F; ASTOLFI M; RIZZO E; SAMETTI S; CUTTICA A; ROSATO R; FARINA L; BOCCADORO M; BENEDETTI F; PILERI A; TARELLA C | |
| Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL) | 2004 | Marco Ladetto; Barbara Mantoan; Federica De Marco; Berardino Pollio; Daniela Drandi; Irene Ricca; Sonia Vallet; Mara Compagno; Monica Astolfi; Maria Dell’Aquila; Roberto Francese; Gloria Pagliano; Luigia Monitillo; Giacomo Tamponi; Mario Boccadoro; Corrado Tarella | |
| Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo) | 2004 | Marco Ladetto; Sonia Vallet; Paolo Corradini; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Paolo Coser; Alessio Perrotti; Caterina Patti; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Monica Astolfi; Alessandro Pileri; Mario Boccadoro; Corrado Tarella | |
| Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer | 2001 | Corradini, P.; Voena, C.; Astolfi, M.; Dell'Oro, S.; Pilotti, S.; Arrigoni, G.; Bregni, M.; Pileri, A.; Gianni, A.M. | |
| Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. | 1999 | Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A | |
| Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma | 2003 | Bruno B; Ladetto M; Mordini N; Astolfi M; Rotta M; Cimolin L; Compagno M; Veneziano L; Aitoro G; Gallamini A ; Storb R; Boccadoro M | |
| Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. | 1997 | CORRADINI P; ASTOLFI M; CHERASCO C; M. LADETTO; VOENA C; CARACCIOLO D; PILERI A; TARELLA C. | |
| MOLECULAR REMISSION IN A MULTIPLE MYELOMA PATIENT AFTER A NON MYELOABLATIVE ALLOGENEIC TRANSPLANT: PROOF OF PRINCIPLE | 2001 | Bruno B; Ladetto M; Astolfi M; Sametti S; Veneziano L; Aitoro G; Giaccone L; Palumbo A; Pileri A; Boccadoro M; Storb R | |
| PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy. | 2003 | Ladetto M; Drandi D; Volpato F; Astolfi M; Voena C; Compagno M; Novarino A; Pollio B; Addeo A; Ricca I; Falco P; Cavallo F; Vallet S; Corradini P; Pileri A; Tamponi G; Palumbo A; Bertetto O; Boccadoro M; Tarella C |